<p>A: absolute lymphocyte number in draining lymph nodes, spleen, and non-draining lymph nodes is decreased in rapamycin-treated mice compare to controls in a dose-dependent fashion. B: quantification of the different sub-populations of lymphocytes: B lymphocytes (B, CD19<sup>+</sup>B220<sup>+</sup>), T (CD3<sup>+</sup>), T CD4<sup>+</sup> (CD3<sup>+</sup>CD4<sup>+</sup>) and T CD8<sup>+</sup> (CD3<sup>+</sup>CD8<sup>+</sup>) cells. * p<0.05, *** p<0.001. White histogram bars: control mice, black histogram bars: rapamycin treated mice (3 mg/kg/day). C: percent of T or B lymphocytes in draining lymph nodes. D: Representative dot plot of flow cytometry analysis of draining lymph nodes for percentage of pre-activated CD4<sup>+</sup> T cell (CD...
a<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle control for 3 days...
a<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle. Some SU5416-treat...
<p>EAU and daily treatment of rapamycin (1.5 µg/mouse) are described previously. On day 21, the sple...
<p>Representative dot plot of flow cytometry analysis of draining lymph nodes for percent of Treg (C...
<p>(<b>A</b>) CD4<sup>+</sup> FoxP3<sup>+</sup> regulatory T-cells (Tregs) were analyzed in the bloo...
<p>Naïve WT and MyD88ΔT mice were CD4<sup>+</sup> T cell depleted and vaccinated with strain #55. Ra...
<p>IL-2 complexes were combined with selected agents to alleviate the unintended expansion and activ...
<p>B10.RIII mice were treated with or without daily rapamycin (1.5 µg/mouse) as described previously...
<p>(<b>A</b>) Representative sections of H&E-stained VWAT of Ve- or Rapa-treated mice. Scale bars re...
<p>(A) FVB and C57BL/6 mice were treated according to the protocol shown in Figure 3A. Mouse serum s...
<p>(<b>A</b>) Percentages of various kinds of lymphocytes in TACs of naïve mice and mice of early an...
<p>EAU induction and rapamycin treatment are described previously. On day 21, the splenocytes were h...
<p>A: Histogram plot of the shift of CCR7 expression in controls and rapamycin-treated (3 mg/kg/day)...
<p>P14 CD44<sup>lo</sup>CD8<sup>+</sup> T<sub>N</sub> were stimulated <i>in vitro</i> with B6-derive...
Background. Rapamycin (Rapa) is an immunosuppressant that is used in patients and animal models to c...
a<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle control for 3 days...
a<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle. Some SU5416-treat...
<p>EAU and daily treatment of rapamycin (1.5 µg/mouse) are described previously. On day 21, the sple...
<p>Representative dot plot of flow cytometry analysis of draining lymph nodes for percent of Treg (C...
<p>(<b>A</b>) CD4<sup>+</sup> FoxP3<sup>+</sup> regulatory T-cells (Tregs) were analyzed in the bloo...
<p>Naïve WT and MyD88ΔT mice were CD4<sup>+</sup> T cell depleted and vaccinated with strain #55. Ra...
<p>IL-2 complexes were combined with selected agents to alleviate the unintended expansion and activ...
<p>B10.RIII mice were treated with or without daily rapamycin (1.5 µg/mouse) as described previously...
<p>(<b>A</b>) Representative sections of H&E-stained VWAT of Ve- or Rapa-treated mice. Scale bars re...
<p>(A) FVB and C57BL/6 mice were treated according to the protocol shown in Figure 3A. Mouse serum s...
<p>(<b>A</b>) Percentages of various kinds of lymphocytes in TACs of naïve mice and mice of early an...
<p>EAU induction and rapamycin treatment are described previously. On day 21, the splenocytes were h...
<p>A: Histogram plot of the shift of CCR7 expression in controls and rapamycin-treated (3 mg/kg/day)...
<p>P14 CD44<sup>lo</sup>CD8<sup>+</sup> T<sub>N</sub> were stimulated <i>in vitro</i> with B6-derive...
Background. Rapamycin (Rapa) is an immunosuppressant that is used in patients and animal models to c...
a<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle control for 3 days...
a<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle. Some SU5416-treat...
<p>EAU and daily treatment of rapamycin (1.5 µg/mouse) are described previously. On day 21, the sple...